Spanish translation of: Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis.

Carles, Joan; A Medina-Lopez, Rafael; Puente, Javier; Gómez-Ferrer, Álvaro; Casas Nebra, Javier; Isabel Sáez Medina, María; J Ribal, Maria; Rodríguez-Antolín, Alfredo; Luís Álvarez-Ossorio, José; Francisco Suárez-Novo, José; Moretones Agut, Cristina; Srinivasan, Shankar; Ortiz, Jorge; Fizazi, Karim

doi:10.25402/FON.23790795.v2

ARAMIS Spanish subgroup_FO_Spanish translation.pdf (803.46 kB)

Spanish translation of: Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis.

journal contribution

posted on 2023-07-27, 12:55 authored by Joan Carles, Rafael A Medina-Lopez, Javier Puente, Álvaro Gómez-Ferrer, Javier Casas Nebra, María Isabel Sáez Medina, Maria J Ribal, Alfredo Rodríguez-Antolín, José Luís Álvarez-Ossorio, José Francisco Suárez-Novo, Cristina Moretones Agut, Shankar Srinivasan, Jorge Ortiz, Karim Fizazi

This is a translation of: Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis. J Carles et al. Future Oncol. 19(12), 819–828 (2023).

History

Usage metrics

Keywords

Spanish Spain PSA progression prostate-specific antigen nonmetastatic metastasis-free survival darolutamide castration-resistant prostate cancer androgen receptor inhibitor

Licence

CC BY-NC-ND 4.0

Spanish translation of: Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis.

History

Usage metrics

Categories

Keywords

Licence

Exports